Cargando…

Publisher Correction: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

Detalles Bibliográficos
Autores principales:	Han, Shujun, Ren, Yibo, He, Wangxiao, Liu, Huadong, Zhi, Zhe, Zhu, Xinliang, Yang, Tielin, Rong, Yu, Ma, Bohan, Purwin, Timothy J., Ouyang, Zhenlin, Li, Caixia, Wang, Xun, Wang, Xueqiang, Yang, Huizi, Zheng, Yan, Aplin, Andrew E., Liu, Jiankang, Shao, Yongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Publisher Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889394/ https://www.ncbi.nlm.nih.gov/pubmed/29626208 http://dx.doi.org/10.1038/s41467-018-03710-1

Ejemplares similares

ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
por: Han, Shujun, et al.
Publicado: (2018)

Gene signature reveals decreased SOX10-dependent transcripts in malignant cells from immune checkpoint inhibitor-resistant cutaneous melanomas
por: Purwin, Timothy J., et al.
Publicado: (2023)

CIC Is a Mediator of the ERK1/2-DUSP6 Negative Feedback Loop
por: Ren, Yibo, et al.
Publicado: (2020)

Publisher Correction: RING tetramerization is required for nuclear body biogenesis and PML sumoylation
por: Wang, Pengran, et al.
Publicado: (2018)

Influence of Sox protein SUMOylation on neural development and regeneration
por: Chang, Kun-Che
Publicado: (2021)

Generation of a Quantitative Luciferase Reporter for Sox9 SUMOylation
por: Saotome, Hideka, et al.
Publicado: (2020)

Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma
por: Tiago, Manoela, et al.
Publicado: (2020)

SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects
por: Rosenbaum, Sheera R., et al.
Publicado: (2021)

SUMOylation Represses Nanog Expression via Modulating Transcription Factors Oct4 and Sox2
por: Wu, Yongyan, et al.
Publicado: (2012)

SUMOylation Is Required for ERK5 Nuclear Translocation and ERK5-Mediated Cancer Cell Proliferation
por: Erazo, Tatiana, et al.
Publicado: (2020)

Publisher Correction: SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis
por: Athwal, Varinder S., et al.
Publicado: (2019)

Publisher Correction: FGF signalling controls the specification of hair placode-derived SOX9 positive progenitors to Merkel cells
por: Nguyen, Minh Binh, et al.
Publicado: (2018)

Publisher Correction: Integrating chemical and mechanical signals through dynamic coupling between cellular protrusions and pulsed ERK activation
por: Yang, Jr-Ming, et al.
Publicado: (2019)

Publisher Correction: Integrating chemical and mechanical signals through dynamic coupling between cellular protrusions and pulsed ERK activation
por: Yang, Jr-Ming, et al.
Publicado: (2019)

Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development
por: Deng, Rong, et al.
Publicado: (2015)

Publisher Correction: Cardiac disruption of SDHAF4-mediated mitochondrial complex II assembly promotes dilated cardiomyopathy
por: Wang, Xueqiang, et al.
Publicado: (2022)

SUMOylated SoxE factors recruit Grg4 and function as transcriptional repressors in the neural crest
por: Lee, Pei-Chih, et al.
Publicado: (2012)

Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation
por: Paez-Mayorga, Jesus, et al.
Publicado: (2018)

SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1
por: Qu, Yingying, et al.
Publicado: (2014)

Multifocal BRAF(V600E)-Mutated Melanoma in situ on the Foot
por: Iwama, Eimei, et al.
Publicado: (2015)

ERK5 is activated by oncogenic BRAF and promotes melanoma growth
por: Tusa, Ignazia, et al.
Publicado: (2018)

Abl Kinase Regulation by BRAF/ERK and Cooperation with Akt in Melanoma
por: Jain, Aditi, et al.
Publicado: (2017)

BRAF Mutation (V600E) Prevalence in Mexican Patients Diagnosed with Melanoma
por: Zepeda-Lopez, Priscilla Denise, et al.
Publicado: (2016)

SOX2 Expression Is Regulated by BRAF and Contributes to Poor Patient Prognosis in Colorectal Cancer
por: Lundberg, Ida V., et al.
Publicado: (2014)

miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2
por: Liu, Szu-Mam, et al.
Publicado: (2014)

Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
por: Capparelli, Claudia, et al.
Publicado: (2022)

Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques
por: Schoenewolf, Nicola L., et al.
Publicado: (2012)

Publisher Correction: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes
por: Li, Xueling, et al.
Publicado: (2018)

Publisher Correction: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes
por: Li, Xueling, et al.
Publicado: (2017)

Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer
por: Zaballos, Miguel A., et al.
Publicado: (2022)

Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations
por: Shackelford, Rodney, et al.
Publicado: (2014)

Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib
por: Ali, Siraj M., et al.
Publicado: (2014)

Enrichment of SOX2-Positive Cells in BRAF V600E Mutated and Recurrent Ameloblastoma
por: Tseng, Chih-Huang, et al.
Publicado: (2022)

Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation
por: Abdel-Hafiz, Hany A, et al.
Publicado: (2012)

ERK2 phosphorylation of serine 77 regulates Bmf pro-apoptotic activity
por: Shao, Y, et al.
Publicado: (2012)

Drugging SUMOylation for neuroprotection and oncotherapy
por: Bernstock, Joshua D., et al.
Publicado: (2018)

Localized Epidermal Cysts as a Radiation Recall Phenomenon in a Melanoma Patient Treated with Radiotherapy and the BRAF Inhibitor Vemurafenib
por: Houriet, Carine, et al.
Publicado: (2014)

Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation
por: Lochhead, Pamela A., et al.
Publicado: (2016)

Publisher Correction: Vimentin knockout results in increased expression of sub-endothelial basement membrane components and carotid stiffness in mice
por: Langlois, Benoit, et al.
Publicado: (2018)

Ubc9 fusion-directed SUMOylation identifies constitutive and inducible SUMOylation
por: Jakobs, Astrid, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ke26mo8f09prpnnn3hlhgvbjuo